Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · IEX Real-Time Price · USD
18.63
+1.02 (5.79%)
At close: Mar 27, 2024, 4:00 PM
17.07
-1.56 (-8.37%)
After-hours: Mar 27, 2024, 4:13 PM EDT
Enliven Therapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for ELVN stock has a target of 27, which predicts an increase of 44.93% from the current stock price of 18.63.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 29, 2023.
Analyst Ratings
According to 1 stock analyst, the rating for ELVN is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Mar '23 |
---|---|
Strong Buy | 1 |
Buy | 0 |
Hold | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Jefferies | Jefferies | Strong Buy Initiates $27 | Strong Buy | Initiates | $27 | +44.93% | Mar 29, 2023 |
TD Cowen | TD Cowen | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 3, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.56
from -2.01
EPS Next Year
-2.95
from -2.56
Revenue Forecast
Revenue | 2024 | 2025 |
---|---|---|
High | n/a | n/a |
Avg | n/a | n/a |
Low | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
EPS Forecast
EPS | 2024 | 2025 |
---|---|---|
High | -2.33 | -2.52 |
Avg | -2.56 | -2.95 |
Low | -2.74 | -3.65 |
EPS Growth
EPS Growth | 2024 | 2025 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.